2026-02-22 — 20 stories, 1 analyzed
CDC emergency press release: 51 hospitalized infants across 19 states, 0 deaths, ByHeart Whole Nutrition formula confirmed source, first U
Phase 3 RCT of gene therapy fordadistrogene movaparvovec for Duchenne muscular dystrophy reports safety and efficacy results.
CDC reports an extensively drug-resistant Salmonella outbreak linked to moringa powder capsules with hospitalizations.
Expanding Salmonella outbreak linked to dietary supplements now affects 65 people across 28 states with a new recall issued.
New Salmonella outbreak linked to Live It Up Super Greens supplements affecting 45 people across 21 states.
Ongoing Salmonella outbreak linked to raw oysters has spread to nearly half of US states with 64 cases reported.
Ongoing Listeria outbreak linked to prepared meals continues despite recalls, prompting urgent CDC consumer warnings.
CDC expands Listeria outbreak alert to include additional prepared foods, broadening the scope of a significant foodborne illness event.
Listeria outbreak in prepared meals grows with 3 additional illnesses and 1 additional death reported.
CDC report documents a sharp rise in dangerous drug-resistant bacteria, a critical antimicrobial resistance surveillance finding.
Salmonella outbreak linked to recalled eggs has sickened nearly 100 people across 14 states.
Fight Aging! newsletter aggregates current longevity research news and commentary directly covering the topic domain.
Partial epigenetic reprogramming of neurons restoring cognitive function in aged mice is a core longevity/rejuvenation research finding.
US withdrawal from WHO has significant implications for global pandemic preparedness and international disease surveillance cooperation.
Identifies blood transcriptional signatures associated with age and survival in longevity-focused cohort studies, directly relevant to aging biomarkers.
Epigenetic clocks of biological aging predict incident cognitive impairment and dementia in a large women's cohort, linking aging biomarkers to neurodegeneration.
Review of neoadjuvant therapy advances for cisplatin-ineligible muscle-invasive bladder cancer including emerging agents TAR-200 and enfortumab vedotin plus pembrolizumab.
First-in-human phase 1/2a trial of oncolytic HSV T3011 expressing IL-12 and PD-1 antibody for advanced solid tumors including HNSCC.
RCT protocol for integrated infectious disease and substance use disorder treatment for severe injection-related infections.
Clinical validation of the first commercial immunoassay for plasma brain-derived tau, a significant diagnostic advance for neurological disease.